253P Immunopheresis to remove soluble TNF receptors as a novel immunotherapy for patients with advanced breast cancer

Autor: Wysocki, P.J., Tomczak, P., Jankowski, T., Nowikiewicz, T., Manax, V., Florin, L., Segal, R., Djazouli, K.M., Bilgrami, S., Marleau, A., Ostrowski, A.
Zdroj: In ESMO Open May 2023 8(1) Supplement 4
Databáze: ScienceDirect